AbbVie
ABBV
#25
Rank
HK$4.037 T
Marketcap
HK$2,284
Share price
1.07%
Change (1 day)
34.29%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

EPS for AbbVie (ABBV)

EPS in 2023 (TTM): HK$28.81

According to AbbVie's latest financial reports the company's current EPS (TTM) is HK$27.99. In 2022 the company made an earnings per share (EPS) of HK$52.20 an increase over its 2021 EPS that were of HK$50.86.

EPS history for AbbVie from 2011 to 2023

Annual EPS

Year EPS Change
2023 (TTM)HK$28.81-44.81%
2022HK$52.202.63%
2021HK$50.86125.21%
2020HK$22.58-45.69%
2019HK$41.5848.35%
2018HK$28.037.6%
2017HK$26.05-9.3%
2016HK$28.7215.48%
2015HK$24.87185.53%
2014HK$8.71-57.11%
2013HK$20.31-21.69%
2012HK$25.9455.73%
2011HK$16.66

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
HK$5.96-78.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$242.00 764.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$127.17 354.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$18.50-33.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-HK$24.31-186.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$35.44 26.59%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$52.37 87.09%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
HK$22.56-19.41%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
HK$55.27 97.45%๐Ÿ‡บ๐Ÿ‡ธ USA